Joanne M. Donovan, M.D., Ph.D., is a distinguished medical professional who currently holds the position of Chief Medical Officer at Edgewise Therapeutics Inc. Dr. Donovan's career is marked by her extensive expertise in the fields of gastroenterology, hepatology, and clinical development. She earned her M.D. and Ph.D. from the University of Pennsylvania, where she also completed her residency and fellowship training. Her academic journey laid a strong foundation for her subsequent contributions to medical research and patient care. Throughout her career, Dr. Donovan has held several key leadership roles in the biopharmaceutical industry. Prior to joining Edgewise Therapeutics, she served as the Chief Medical Officer at Synlogic, where she played a pivotal role in advancing the company's clinical programs in rare genetic diseases. Her work has been instrumental in driving the development of novel therapies, and she has authored numerous publications in peer-reviewed journals, reflecting her commitment to advancing scientific knowledge. Her strategic vision and deep understanding of clinical development have made her a valuable asset to the companies she has worked with. At Edgewise Therapeutics, Dr. Donovan leads the clinical development efforts for the company's portfolio of muscle disease therapies. Her role involves overseeing the design and execution of clinical trials, ensuring that the company's innovative treatments meet the highest standards of safety and efficacy. Under her leadership, Edgewise Therapeutics is poised to make significant strides in addressing unmet medical needs in neuromuscular diseases. Dr. Donovan's dedication to improving patient outcomes and her ability to navigate the complexities of drug development are central to her success as Chief Medical Officer.